Navigation Links
FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
Date:5/4/2010

ts, as measured by average PERMP total scores over the course of one assessment day, as well as at each time point measured.  The PERMP assessments were administered at predose (-0.5 hours) and at two, four, eight, 10, 12, and 14 hours postdose.

In addition to PERMP, the investigators measured the efficacy of Vyvanse using the ADHD-RS with adult prompts.  In this study, Vyvanse demonstrated a reduction (approximately 52 percent) from baseline in average ADHD-RS total scores in adults, from 37.2 at baseline to 18.1 at end point.  Adult patients taking placebo demonstrated a reduction (approximately 21 percent) in average ADHD-RS total scores, from 37.2 at baseline to 29.6 at end point.

The most frequently reported treatment-emergent adverse events reported by five or more percent of patients during the dose-optimization phase were decreased appetite, dry mouth, headache, insomnia (trouble sleeping), upper respiratory tract infection, irritability, nausea, anxiety, anorexia, diarrhea, and fatigue.

About Vyvanse

Vyvanse, which was introduced in the United States in July 2007 for the treatment of ADHD in children aged 6 to 12 years and approved in April 2008 to treat ADHD in adults, is currently available in six once-daily dosage strengths of 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg.

Vyvanse is a therapeutically inactive prodrug stimulant in which d-amphetamine is covalently bonded to l-lysine.  After oral ingestion, it is converted to pharmacologically active d-amphe
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
2. FDA Approves New Device for Adults with Severe and Persistent Asthma
3. FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels
4. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
5. FDA Approves First Totally Implanted Hearing System
6. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
7. FDA Approves Name Change for Heartburn Drug Kapidex
8. FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
9. FDA Approves First New Inhaled Antibiotic for CF in More Than a Decade
10. FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinsons Disease
11. FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 Research and Markets ... the "Surgical/Operating Microscopes Market by Application & ... report to their offering.      (Logo: ... is poised to reach $806.6 million by 2020 ... of 12.3% from 2015 to 2020. , ,Major ...
(Date:5/29/2015)...  Epic Sciences announced today that the company will ... resistant prostate cancer patients, at the 2015 annual ... This application expands the investigational utility of Epic ... to characterize circulating tumor cell (CTC) genomic alterations. ... heterogeneous clonal CTC populations harboring separate genetic alterations. ...
(Date:5/29/2015)... 2015 Educating the community continues to ... the Advancement of Wound Care (AAWC), which was ... AAWC,s corporate partners, the Association provides medical professionals ... AAWC website at http://aawconline.org/education-for-the-generalist/ . The portal ... links to various CME/CEU educational programs. This education ...
Breaking Medicine Technology:Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3The Association for the Advancement of Wound Care Educates the Public 2
... 7, 2011 Diplomat Specialty Pharmacy, the nation,s largest, privately ... of MichBio,s Good to Great Award. ... as a company whose business concept, entrepreneurialism, leadership, work ethic ... produce a leap forward in the past year," said Stephen ...
... EXTON, Pa., Nov. 7, 2011 Kensey Nash Corporation (Nasdaq: ... Small Business Innovation Research (SBIR) grant from the National Institutes ... Nash Corporation a two-year, $1.9 million Phase II SBIR grant ... for applications in tendon repair procedures.  The Company will develop ...
Cached Medicine Technology:Diplomat Specialty Pharmacy Recipient of MichBio Good to Great Award; Also Featured in Pure Michigan Video Exemplifying Flint's Resurgence and Michigan's Future 2Diplomat Specialty Pharmacy Recipient of MichBio Good to Great Award; Also Featured in Pure Michigan Video Exemplifying Flint's Resurgence and Michigan's Future 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 New ... from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) ... a new product line of peptide stable ... of Tryptides™, or isotope labeled tryptic peptides, offers ... interest and is now readily accessible to the ...
(Date:5/29/2015)... On May 28th, TheCelebrityDresses.com released their new ... party dresses. Most of the styles in their new ... more than 80 styles of sexy cocktail dresses and ... design elements coming with the new release are color ... design. Many of the new styles are made of ...
(Date:5/28/2015)... On Monday, June 1, KORT, The Best in ... in Shelbyville, Kentucky . Clinic Director, Chad Flickinger, PT, MPT, ... patients , “ Shelbyville is a growing community and ... to better serve the residents of Shelby County. At KORT, ... as possible by providing accessible and immediate care in a ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 External Counterpulsation ... and all over the United States. There are a ... disease, who can experience symptoms of angina and these ... heart stents and/or bypass surgery. , “No option” patients ... to coronary artery disease that is considered unacceptable for ...
(Date:5/28/2015)... 28, 2015 Today the National Resident ... for the 2015 Main Residency Match®. A record-number ... were filled when the matching algorithm was processed. ... during the Match Week Supplemental Offer and Acceptance Program® ... are pleased with the outcome of the 2015 Main ...
Breaking Medicine News(10 mins):Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3Health News:External Counterpulsation (EECP/ECP) a New Heart Disease Therapy Helps People of Calgary with Unstable Angina 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3
... latest study researchers say health professionals and patients require ... associated with over the counter drugs. Of the many ... most common condition that people choose to treat by ... commonly treated ailments include heartburn, migraine, period pain, coughs, ...
... started with a big bang, bringing hope and aspirations for people// ... own. 2001 opened with it Pandora ’s Box of ... first internationally reported disaster was in 2000 on February 1st in ... Soon after a whole string of disasters followed. ,Droughts ...
... a group of genes known as a gene signature, that ... at high risk for having a future cancer recurrence .// ... tumor samples from 209 lymph-node-negative breast cancer patients were examined. ... initial cancer treatment and varied in age and in their ...
... skin cancer – melanoma ,however researchers as the number of ... of patients surviving the disease. // Two new studies show ... of cancer. In a study conducted by researchers on patients ... was discovered that melanoma patients with higher levels of sun ...
... discovery could help prevent complications for pregnant women with ... after the 20th week of pregnancy and is characterized ... in the urine. In severe cases it can lead ... causes the mother to suffer a series of potentially ...
... study, advanced imaging techniques reveals unexpected structural differences in ... compared detailed images of the brain structure // of ... from 27 healthy patients. ,Results showed the amygdala ... research has linked to the brain's reward processing system ...
Cached Medicine News:Health News:SARS (Bird Flu) spreading in the Asian continent 2
... full weight. Footstep tilts out of the way ... raised and lowered by either a finger switch ... corded foot switch. Dual rotation locks on both ... the chair 330 without changing position. A patented ...
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles....
Sandown chair, with hydraulic lift, sliding headrest and armrests with glides. Black vinyl....
Heine Beta 200 Streak Retinoscope 2.5v...
Medicine Products: